Optimising inhaled therapy for patients with asthma.

Bansal, Aarti; Franklin, Lauren; Twohig, Helen

Abstract

What you need to know
Sub-optimally controlled asthma is common, in part because of normalisation of symptoms, underuse of preventer therapy, overuse of reliever therapy, and poor inhaler technique. Ensuring patients are using the right inhaled medicine and that this is getting to the right place in the airways is critical to improving asthma control
Right inhaled medicine: Adherence to inhaled corticosteroid preventer therapy can be encouraged by explaining the role of airway inflammation in causing asthma symptoms and considering the use of inhaled corticosteroid (ICS)-formoterol combination inhaler regimens
Right place: Ensure patients have the most appropriate inhaler device type, based on their inhaler technique and preferences, which will maximise the likelihood that medication reaches their airways

Citation

Bansal, A., Franklin, L., & Twohig, H. (in press). Optimising inhaled therapy for patients with asthma. BMJ, 386, 1-6. https://doi.org/10.1136/bmj-2024-080353

• Journal Article Type: Article
• Acceptance Date: Sep 20, 2024
• Online Publication Date: Sep 20, 2024
• Deposit Date: Dec 6, 2024
• Publicly Available Date: Dec 6, 2024
• Journal: BMJ (Clinical research ed.)
• Print ISSN: 0959-8138
• Electronic ISSN: 1756-1833
• Publisher: BMJ Publishing Group
• Peer Reviewed: Peer Reviewed
• Volume: 386
• Article Number: e080353
• Pages: 1-6
• DOI: https://doi.org/10.1136/bmj-2024-080353
• Keywords: Asthma - drug therapy, Anti-Asthmatic Agents - administration & dosage - therapeutic use, Nebulizers and Vaporizers, Administration, Inhalation, Humans, Bronchodilator Agents - administration & dosage - therapeutic use
• Public URL: https://keele-repository.worktribe.com/output/948624